file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
2601 | GRAFT-DERIVED | 1 | 1 | 4 |
2602 | GRAFT-RESIDENT | 2 | 1 | 35 |
2603 | GRANZYMES | 1 | 1 | 18 |
2604 | GROUP-ABO-INCOMPATIBLE | 1 | 1 | 5 |
2605 | GROWTH-FACTOR-BETA | 1 | 1 | 8 |
2606 | GUIDANCE | 1 | 1 | 34 |
2607 | GUIDELINES | 2 | 1 | 58 |
2608 | HAEMAGGLUTINATING | 1 | 1 | 23 |
2609 | HAZARDOUS | 1 | 1 | 16 |
2610 | HEALTH | 2 | 1 | 213 |
2611 | HELP | 1 | 1 | 9 |
2612 | HELPING | 1 | 1 | 13 |
2613 | HEMATOLOGIC | 2 | 1 | 8 |
2614 | HEPATECTOMIZED | 1 | 1 | 3 |
2615 | HEPATOCELLULAR-CARCINOMA | 1 | 1 | 428 |
2616 | HETEROGENEITY | 1 | 1 | 25 |
2617 | HETEROGRAFTED | 1 | 1 | 23 |
2618 | HETEROPHIL | 1 | 1 | 27 |
2619 | HETEROTOPIC | 3 | 1 | 16 |
2620 | HIGH-INCIDENCE | 1 | 1 | 10 |
2621 | HIGH-PERMEABILITY | 1 | 1 | 35 |
2622 | HISTOMETRIC | 1 | 1 | 18 |
2623 | HISTORICAL-PERSPECTIVE | 1 | 1 | 1 |
2624 | HOST-ALLOGRAFT | 1 | 1 | 19 |
2625 | HUB | 1 | 1 | 10 |
2626 | HUMAN-KIDNEY | 3 | 1 | 76 |
2627 | HUMAN-LEUKEMIC | 1 | 1 | 52 |
2628 | HUMAN-SUBJECTS | 1 | 1 | 4 |
2629 | HUMAN-TO-RAT | 1 | 1 | 4 |
2630 | HUMANIZED | 2 | 1 | 32 |
# | Word | Recs | TLCS | TGCS |
2631 | HYPERCHOLESTEROLEMIA | 1 | 1 | 94 |
2632 | HYPERNATREMIA | 1 | 1 | 4 |
2633 | HYPOTHERMIA | 4 | 1 | 73 |
2634 | HYPOTHESES | 1 | 1 | 8 |
2635 | HYPOTHESIS | 1 | 1 | 6 |
2636 | ICAM1 | 1 | 1 | 22 |
2637 | IGG2 | 1 | 1 | 3 |
2638 | II-EXPRESSING | 1 | 1 | 18 |
2639 | IMMUNE-MEDIATED | 2 | 1 | 117 |
2640 | IMMUNE-SYSTEM | 1 | 1 | 103 |
2641 | IMMUNO | 2 | 1 | 43 |
2642 | IMMUNOCOMPETENT | 1 | 1 | 33 |
2643 | IMMUNODEFICIENCY | 2 | 1 | 21 |
2644 | IMMUNODEPLETIVE | 1 | 1 | 1 |
2645 | IMMUNOFLUORESCENCE | 2 | 1 | 25 |
2646 | IMMUNOLOGISTS | 1 | 1 | 13 |
2647 | IMMUNOMODULATORS | 1 | 1 | 10 |
2648 | IMMUNOPATHOLOGIC | 1 | 1 | 113 |
2649 | IMMUNOPHARMACOLOGIC | 1 | 1 | 13 |
2650 | IMMUNOSTIMULATORY | 2 | 1 | 31 |
2651 | IMMUNOSUPPRESSOR | 1 | 1 | 2 |
2652 | IMMUNOTHERAPY | 8 | 1 | 173 |
2653 | IMPLICATED | 1 | 1 | 163 |
2654 | IMPLICATION | 2 | 1 | 17 |
2655 | IN-UTERO | 1 | 1 | 18 |
2656 | INCLUSION | 1 | 1 | 18 |
2657 | INDIVIDUALIZING | 1 | 1 | 8 |
2658 | INFLAMMATORY | 5 | 1 | 88 |
2659 | INFLUENCING | 4 | 1 | 25 |
2660 | INHIBITOR-2 | 1 | 1 | 25 |
# | Word | Recs | TLCS | TGCS |
2661 | INNERVATION | 1 | 1 | 6 |
2662 | INSIGHT | 1 | 1 | 1 |
2663 | INTELLIGENT | 1 | 1 | 8 |
2664 | INTERFERON-ALPHA | 2 | 1 | 22 |
2665 | INTERLEUKIN-1 | 1 | 1 | 125 |
2666 | INTRABONE | 1 | 1 | 10 |
2667 | INTRACELLULAR | 1 | 1 | 2 |
2668 | INTRAVITREAL | 1 | 1 | 4 |
2669 | INVERTEBRATES | 1 | 1 | 12 |
2670 | INVOLVED | 2 | 1 | 84 |
2671 | IONS | 1 | 1 | 2 |
2672 | ISCHEMIC | 3 | 1 | 69 |
2673 | ISCHEMICALLY | 1 | 1 | 17 |
2674 | ISLET-DERIVED | 1 | 1 | 33 |
2675 | ISOMERASE | 2 | 1 | 53 |
2676 | ISOMERASES | 1 | 1 | 104 |
2677 | JEJUNAL | 1 | 1 | 41 |
2678 | KERATOPLASTY | 2 | 1 | 7 |
2679 | L-SELECTIN-DEPENDENT | 1 | 1 | 38 |
2680 | LAVAGE | 1 | 1 | 5 |
2681 | LCMV | 1 | 1 | 8 |
2682 | LETHALLY | 1 | 1 | 3 |
2683 | LEUKEMIA-1 | 1 | 1 | 5 |
2684 | LEUKOREDUCTION | 1 | 1 | 28 |
2685 | LEUKOTRIENE | 2 | 1 | 7 |
2686 | LIGAND-MEDIATED | 1 | 1 | 23 |
2687 | LIGATION | 2 | 1 | 7 |
2688 | LIKELY | 1 | 1 | 25 |
2689 | LILLY | 1 | 1 | 106 |
2690 | LIPID | 5 | 1 | 55 |
# | Word | Recs | TLCS | TGCS |
2691 | LIPOSOMAL | 3 | 1 | 27 |
2692 | LIVER-FUNCTION | 1 | 1 | 11 |
2693 | LOAD | 1 | 1 | 2 |
2694 | LOCALIZATIONS | 1 | 1 | 6 |
2695 | LONG-LASTING | 1 | 1 | 8 |
2696 | LOW-SOLUBILITY | 1 | 1 | 35 |
2697 | LPR | 1 | 1 | 16 |
2698 | LYMPH-NODE | 1 | 1 | 18 |
2699 | LYMPHNODES | 1 | 1 | 2 |
2700 | LYMPHO-PROLIFERATIVE | 1 | 1 | 26 |
2701 | LYMPHOCYTE-TRANSFORMING | 1 | 1 | 67 |
2702 | LYMPHOCYTURIA | 1 | 1 | 27 |
2703 | LYMPHOMAS | 2 | 1 | 23 |
2704 | LYSOZYMURIA | 1 | 1 | 27 |
2705 | MA6858 | 1 | 1 | 25 |
2706 | MACROCYCLIC | 1 | 1 | 10 |
2707 | MAINTAINED | 3 | 1 | 68 |
2708 | MALONONITRILAMIDES | 1 | 1 | 22 |
2709 | MANDIBULAR | 2 | 1 | 8 |
2710 | MANKINDS | 1 | 1 | 13 |
2711 | MARKING | 1 | 1 | 6 |
2712 | MASSIVE | 4 | 1 | 62 |
2713 | MATCHED | 2 | 1 | 171 |
2714 | MATTER | 1 | 1 | 56 |
2715 | MAVERICKS | 1 | 1 | 13 |
2716 | MEASURING | 2 | 1 | 2 |
2717 | MEDICATIONS | 1 | 1 | 39 |
2718 | MIGRATE | 1 | 1 | 37 |
2719 | MILLENNIA | 1 | 1 | 13 |
2720 | MINIMIZATION | 3 | 1 | 14 |
# | Word | Recs | TLCS | TGCS |
2721 | MIXTURE | 1 | 1 | 5 |
2722 | MODELLING | 2 | 1 | 31 |
2723 | MOLECULAR-BIOLOGICAL | 1 | 1 | 1 |
2724 | MONOCYTES | 1 | 1 | 10 |
2725 | MONOOXYGENASE | 2 | 1 | 5 |
2726 | MP-LPR | 1 | 1 | 16 |
2727 | MRL | 1 | 1 | 16 |
2728 | MUCOSAL | 2 | 1 | 18 |
2729 | MULTIFACTORIAL | 1 | 1 | 4 |
2730 | MULTIPLE-ARTERY | 1 | 1 | 44 |
2731 | MULTIPLE-DRUG | 1 | 1 | 14 |
2732 | MYELIN | 1 | 1 | 23 |
2733 | MYELOABLATIVE | 2 | 1 | 5 |
2734 | NAIVE | 2 | 1 | 48 |
2735 | NANOSPHERIC-SUSPENSION | 1 | 1 | 7 |
2736 | NATURAL-PRODUCTS | 1 | 1 | 166 |
2737 | NECESSARY | 1 | 1 | 17 |
2738 | NECESSITY | 1 | 1 | 19 |
2739 | NEPHROLOGY | 3 | 1 | 16 |
2740 | NEURONAL | 3 | 1 | 47 |
2741 | NEUROPATHIES | 1 | 1 | 19 |
2742 | NEUROPHYSIOLOGICAL | 1 | 1 | 11 |
2743 | NFATC | 1 | 1 | 10 |
2744 | NOD-SCID | 1 | 1 | 21 |
2745 | NON-MYELOABLATIVE | 1 | 1 | 9 |
2746 | NON-RESPONSIVE | 1 | 1 | 4 |
2747 | NON-TRANSPLANTED | 1 | 1 | 8 |
2748 | NONIMMUNOSUPPRESSANT | 1 | 1 | 23 |
2749 | NONMYELOABLATIVE | 1 | 1 | 11 |
2750 | NUCLEIC | 3 | 1 | 28 |
# | Word | Recs | TLCS | TGCS |
2751 | NURSING | 4 | 1 | 6 |
2752 | O-METHYLTRANSFERASE | 1 | 1 | 25 |
2753 | OCCLUSIVE | 1 | 1 | 163 |
2754 | OCCUPANCY | 1 | 1 | 38 |
2755 | OCULAR | 5 | 1 | 59 |
2756 | OPERATIVE | 1 | 1 | 5 |
2757 | ORDERED | 1 | 1 | 17 |
2758 | ORGANIC | 1 | 1 | 20 |
2759 | OUTBRED | 1 | 1 | 14 |
2760 | OVERGROWTHS | 1 | 1 | 23 |
2761 | OVERPRODUCTION | 1 | 1 | 20 |
2762 | P-450-LINKED | 2 | 1 | 5 |
2763 | P-GLYCOPROTEIN | 1 | 1 | 35 |
2764 | PAEDIATRIC | 2 | 1 | 4 |
2765 | PANCREA | 1 | 1 | 2 |
2766 | PARALYSIS | 1 | 1 | 11 |
2767 | PARTNERS | 1 | 1 | 71 |
2768 | PASSAGE | 1 | 1 | 19 |
2769 | PASSIVELY | 2 | 1 | 15 |
2770 | PATH | 1 | 1 | 6 |
2771 | PEDIATRIC-PATIENT | 1 | 1 | 26 |
2772 | PENETRATING | 2 | 1 | 7 |
2773 | PENILE | 1 | 1 | 6 |
2774 | PERFORIN | 1 | 1 | 18 |
2775 | PERIODIC | 1 | 1 | 35 |
2776 | PERIPANCREATIC | 1 | 1 | 18 |
2777 | PERIPHERAL-BLOOD | 2 | 1 | 14 |
2778 | PERIPORTAL | 1 | 1 | 37 |
2779 | PERMEABILITY | 1 | 1 | 35 |
2780 | PERSISTING | 2 | 1 | 32 |
# | Word | Recs | TLCS | TGCS |
2781 | PHAGOCYTIC | 2 | 1 | 38 |
2782 | PHAGOCYTOSIS | 2 | 1 | 16 |
2783 | PHARMACOECONOMIC | 1 | 1 | 13 |
2784 | PLACEMENT | 1 | 1 | 21 |
2785 | PLACENTAL | 1 | 1 | 16 |
2786 | PLATELET | 4 | 1 | 52 |
2787 | PLATELET-AGGREGATION | 2 | 1 | 3 |
2788 | PNEUMONIA | 2 | 1 | 4 |
2789 | POINT | 1 | 1 | 12 |
2790 | POLITICS | 1 | 1 | 12 |
2791 | POLYNEUROPATHY | 2 | 1 | 162 |
2792 | POSTNATAL | 2 | 1 | 26 |
2793 | PP65 | 1 | 1 | 34 |
2794 | PREDOMINANCE | 1 | 1 | 41 |
2795 | PREECLAMPSIA | 1 | 1 | 16 |
2796 | PREMATURE | 1 | 1 | 1 |
2797 | PRENATAL | 2 | 1 | 11 |
2798 | PREOPERATIVE | 4 | 1 | 40 |
2799 | PRESERVED | 3 | 1 | 22 |
2800 | PRETERM | 1 | 1 | 2 |